Radiation therapy for liver cancer and liver metastases
Part of Cancer, Digestive system clinical trials.
This study is testing a radiation therapy technique called SBRT for people with liver cancer or liver metastases. The goal is to see if this precise radiation can help control the disease in patients who are not candidates for other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with liver metastases (cancer that has spread from another part of the body to the liver) or you are 65 or older and have hepatocellular carcinoma (a common type of liver cancer)
- You are referred for a type of radiation therapy called stereotactic body radiation therapy (SBRT), which precisely targets tumors with high-dose radiation
- Your case has been reviewed by a team of cancer specialists (multidisciplinary tumor board)
- You are able to hold your breath for a short time during treatment, as instructed
- You are not eligible for surgery, ablation (procedures that destroy tumors with heat or cold), or liver transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies stereotactic body radiation therapy (high-precision radiation given in a few sessions) for liver metastases when surgery isn’t possible. It may help shrink or control tumors in the liver and delay progression in people whose cancer has not spread outside the liver (or only to areas treated with a curative plan).
This study tests a radiation treatment that uses real-time MRI (an imaging scan) to guide the dose for liver metastases. It may help control tumors while aiming to better protect nearby healthy liver tissue.
This study compares a standard radiation dose plan versus a plan that adjusts the dose based on how the tumor responds to radiation-related measurements. It aims to improve how well stereotactic body radiation therapy (SBRT) treats liver cancer while keeping side effects manageable.
This trial tests a very high, single dose of radiation guided by MRI to destroy liver tumors that have spread from certain cancers. It may be a good option if you have 1 to 3 liver tumors that are away from sensitive organs and your liver is working well.
This trial tests a combination of immunotherapy and high-precision radiation (SBRT) to shrink large or multiple liver tumors in people with hepatocellular carcinoma, with the goal of making them small enough for surgery. It's for people who cannot currently have their tumors removed but might become eligible after treatment.
This trial tests a single, high-dose radiation treatment (SBRT) guided by MRI for people with colorectal cancer that has spread to the liver. The goal is to see if this precise, one-time treatment can effectively control liver tumors while protecting nearby organs.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.